New Horizons Overview

New Horizons in Cancer Research Conference

The New Horizons in Cancer Research Conference Series is hosted annually by the AACR in Shanghai, China. The conference is designed to highlight some of the latest discoveries in cancer science and medicine presented at the AACR Annual Meeting in the U.S., and to provide a dynamic platform for discussions and collaborations on an international scale. Each year, the conference is organized by a committee of distinguished cancer researchers from the U.S. and Asia Pacific, and the interactive four-day program features presentations from international speakers and local experts. Plenary sessions cover the entire cancer research spectrum – from basic, to translational, to clinical – and highlight the latest advances in cancer science and medicine.

In October 2014, the AACR hosted its first major conference in China, the inaugural New Horizons in Cancer Research Conference. The first conference drew more than 750 attendees from 21 countries, and in subsequent years, the New Horizons Conference has quickly become established as a must-attend event. Exhibit sales for the conference have steadily increased with the conference’s success and, each fall, this meeting provides a unique opportunity for scientific interaction for a broad spectrum of more than 500 researchers. The AACR is committed to supporting and promoting collaboration among cancer researchers in China, the Asia Pacific, and around the world, and mobilizing a global effort to defeat cancer. The New Horizons in Cancer Research Conference serves as an exciting platform for forging these collaborations.

The AACR has welcomed the following distinguished keynote speakers to the New Horizons in Cancer Research Conference:

  • 2016: José Baselga is an internationally renowned expert in the development of molecular targeted agents. He is physician-in-chief at Memorial Sloan Kettering Cancer Center and past president of the AACR (2015-2016).
  • 2016: David Baltimore was awarded the Nobel Prize at the age of 37 for research in virology. He is an accomplished researcher, educator, administrator, and public advocate for science and engineering and is considered one of the world’s most influential biologists.
  • 2016: Qimin Zhan is director of the State Key Laboratory of Molecular Oncology and president of the Peking University Health Science Center. His research interest is focused on the molecular pathways involved in the control of cell cycle checkpoint and apoptosis after DNA damage.
  • 2015: Xuetao Cao is president of the Chinese Academy of Medical Sciences and director of China’s National Key Laboratory of Medical Immunology. His major research interests include innate response and inflammation, immune regulation, tumor immunotherapy.
  • 2015: Xiaodong Wang is the director of the National Institute of Biological Sciences (NIBS) in Beijing. The goal of his research laboratory at NIBS is to understand cell death at a molecular level.
  • 2014:  Zhu Chen was presented with the “2014 AACR Award for Distinguished Public Service and Global Impact in Cancer Research in Biomedical Science.” Dr. Chen pioneered the concept of synergistic cancer targeting therapy and, by combining traditional Chinese medicine with Western medicine, provided the first successful model in the treatment of acute promyelocytic leukemia with all-trans retinoic acid and arsenic trioxide.
  • 2014: Frank McCormick is an internationally recognized authority on the Ras signaling pathway. He is also past president of the AACR (2012-2013) and current chair of the AACR’s International Affairs Committee. In these roles, Dr. McCormick was instrumental in helping to develop this conference series.

New Horizons in Cancer Research: Delivering Cures Through Cancer Science
Nov. 2-5, 2016
Shanghai Marriott Hotel Parkview
Shanghai, China

Conference Cochairs
José Baselga, Memorial Sloan Kettering Cancer Center, New York, New York
Scott A. Armstrong, Dana-Farber Cancer Center, Boston, Massachusetts
View program and abstract titles

New Horizons in Cancer Research: Bringing Cancer Discoveries to Patients
Nov. 12-15, 2015
Shanghai Marriott Hotel Parkview
Shanghai, China

Conference Cochairs
Lewis C. Cantley, Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, New York
Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center at Vanderbilt University, Nashville, Tennessee
View program and abstract titles

New Horizons in Cancer Research: Harnessing Breakthroughs, Targeting Cures
Oct. 9-12, 2014
Grand Hyatt Shanghai
Shanghai, China

Conference Cochairs
Scott W. Lowe, Memorial Sloan Kettering Cancer Center, New York, New York
Charles L. Sawyers, Memorial Sloan Kettering Cancer Center, New York, New York
View program and abstract titles